Bliss GVS Pharma Limited

Kvartální We wish to inform you that the Board Meeting of the Company was held today i.e. on Wednesday, August 12, 2026 through Video Conferencing ("VC") / Other Audio Visual Means ("OAVM") with .... FY2027 · Q1BSEPDF 12. srp 2026 před 3 měs. Výroční Annual Report FY2026 FY2026BSEPDF 23. čvn 2026 před 4 měs. Výroční Please find attached herewith the audited standalone & consolidated financial results for the quarter and year ended March 31, 2026 FY2026BSEPDF 12. kvě 2026 před 6 měs. Kvartální Please find enclosed herewith the Outcome of the Board Meeting held on February 10, 2026. FY2026 · Q3BSEPDF 10. úno 2026 před 9 měs. Kvartální Please find attached the unaudited standalone and consolidated financial results for the quarter and half yearly ended September 30, 2025. FY2026 · Q2BSEPDF 6. lis 2025 před 1 r. Kvartální We wish to inform you that the Board of Directors at its meeting held today i.e. Tuesday, July 29, 2025 has considered and approved the unaudited standalone and consolidated financial results .... FY2026 · Q1BSEPDF 29. čvc 2025 před 1 r. Výroční Annual Report FY2025 FY2025BSEPDF 9. čvc 2025 před 1 r. Kvartální Please find attached the outcome of Board Meeting held on Tuesday, January 28, 2025. FY2025 · Q3BSEPDF 28. led 2025 před 2 r. Kvartální Please find attached herewith the Outome of Board Meeting held on today i.e. July 24, 2024 for approval of Unaudited Standalone and Consolidated Financial Results of the Company for the .... FY2025 · Q1BSEPDF 24. čvc 2024 před 2 r. Výroční Annual Report FY2024 FY2024BSEPDF 3. čvc 2024 před 2 r. Výroční Please find attached herewith Outcome of the Board Meeting held on May 02, 2024. FY2024BSEPDF 2. kvě 2024 před 2 r. Kvartální Enclosed herewith the outcome of board meeting held on January 23, 2024 FY2024 · Q3BSEPDF 23. led 2024 před 3 r. Kvartální We would like to inform you that the Board Meeting of the Company was held today i.e. Wednesday, November 01, 2023, at the registered office of the Company. In pursuant to Regulation 30 .... FY2024 · Q2BSEPDF 1. lis 2023 před 3 r. Výroční Annual Report FY2023 FY2023BSEPDF 27. čvn 2023 před 3 r. Výroční We would like to inform you that, the Board Meeting of the Company was held today i.e. Thursday, May 11, 2023 at the registered office of the Company. In pursuant to Regulation .... FY2023BSEPDF 11. kvě 2023 před 3 r. Kvartální We would like to inform you that, Board Meeting of the Company was held today i.e. Tuesday, January 24, 2023 at the registered office of the Company. In pursuant to Regulation 30 and 33 .... FY2023 · Q3BSEPDF 24. led 2023 před 4 r. Kvartální Please find the attachment. FY2023 · Q2BSEPDF 23. lis 2022 před 4 r. Kvartální We would like to inform you that, Board Meeting of the Company was held today i.e. Wednesday, August 03, 2022 at the registered office of the Company. In pursuant to Regulation 30 and 33 .... FY2023 · Q1BSEPDF 3. srp 2022 před 4 r. Výroční Annual Report FY2022 FY2022BSEPDF 6. čvn 2022 před 4 r. Výroční 1.The Audited standalone and consolidated financial results of the Company for the quarter and year ended March 31, 2022 2. Recommended Final dividend of 50% i.e. 0.50 paisa per equity .... FY2022BSEPDF 30. dub 2022 před 4 r. Kvartální We would like to inform you that, Board Meeting of the Company was held today i.e. Saturday, January 29, 2022 at the registered office of the Company. .... FY2022 · Q3BSEPDF 29. led 2022 před 5 r. Kvartální We would like to inform you that, Board Meeting of the Company was held today i.e. Saturday, October 30, 2021 at the registered office of the Company. In pursuant to Regulation 30 and .... FY2022 · Q2BSEPDF 30. říj 2021 před 5 r. Výroční Annual Report FY2021 FY2021BSEPDF 28. srp 2021 před 5 r. Kvartální We would like to inform you that, Board Meeting of the Company was held today i.e. Saturday, July 31, 2021 at the registered office of the Company. In pursuant to Regulation 30 and 33 read .... FY2022 · Q1BSEPDF 31. čvc 2021 před 5 r. Výroční 1. Audited standalone and consolidated financial results of the Company for the quarter and year ended March 31, 2021 along with the audit report with declaration of unmodified opinion .... FY2021BSEPDF 11. kvě 2021 před 5 r. Kvartální We would like to inform you that, Board Meeting of the Company was held today i.e. on Thursday, January 21, 2021 at the registered office of the Company. In pursuant to regulation 30 and .... FY2021 · Q3BSEPDF 21. led 2021 před 6 r. Kvartální We would like to inform you that, Board Meeting of the Company was held today i.e. on Wednesday, October 21, 2020 at the registered office of the Company. In pursuant to Regulation 30 and .... FY2021 · Q2BSEPDF 21. říj 2020 před 6 r. Výroční Annual Report FY2020 FY2020BSEPDF 3. zář 2020 před 6 r. Kvartální We would like to inform you that Board Meeting of the Company was held today i.e. on Thursday, August 20, 2020 at registered office of the Company. In pursuant to Regulation 30 and 33 of .... FY2021 · Q1BSEPDF 20. srp 2020 před 6 r. Výroční We would like to inform you that Board Meeting of the Company was held today i.e. on Tuesday, June 16, 2020 at registered office of the Company. In pursuant to Regulation 30 and 33 of Securities .... FY2020BSEPDF 16. čvn 2020 před 6 r. Kvartální Pursuant to Regulation 30 of SEBI (LODR), 2015, we would like to inform you that Board Meeting of the Company was held today i.e. on Tuesday, February 11, 2020 at the registered office .... FY2020 · Q3BSEPDF 11. úno 2020 před 7 r. Kvartální Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board Meeting of .... FY2020 · Q2BSEPDF 11. lis 2019 před 7 r. Výroční Annual Report FY2019 FY2019BSEPDF 27. srp 2019 před 7 r. Kvartální Pursuant to Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Board Meeting of .... FY2020 · Q1BSEPDF 12. srp 2019 před 7 r. Výroční We would like to inform you that Board Meeting of the Company was held today i.e. on Saturday, May 18, 2019 at registered office of the Company. In pursuant to Regulation 30 and 33 of Securities .... FY2019BSEPDF 18. kvě 2019 před 7 r. Kvartální We like to inform you that Board Meeting of the Company was held today i.e. on Tuesday, January 29, 2019 at 4.00 P.M. at the registered office of the Company. The Board has considered and .... FY2019 · Q3BSEPDF 29. led 2019 před 8 r. Kvartální We like to inform you that Board Meeting of the Company was held today i.e. on Friday, November 02, 2018 at 4.00 P.M. at 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400072. .... FY2019 · Q2BSEPDF 2. lis 2018 před 8 r. Kvartální We like to inform you that Board Meeting of the Company was held today i.e. on Thursday, May 09, 2018 at 4.00 P.M., at 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400072. .... FY2019 · Q1BSEPDF 9. srp 2018 před 8 r. Výroční Regulation 33 of Securities and Exchange Board of India (Listing Obligations and Disclosures Requirements) Regulations, 2015, the Annual Audited Financial Results (Standalone & Consolidated) .... FY2018BSEPDF 17. kvě 2018 před 8 r. Kvartální Financial Result & Limited Review Report FY2018 · Q3BSEPDF 19. led 2018 před 9 r. Kvartální This is to inform you that the Board Meeting of the Company was held today i.e. November 30, 2017 at the registered office of the Company at 04.00 p.m. The Board considered and approved .... FY2018 · Q2BSEPDF 30. lis 2017 před 9 r. Kvartální Outcome of Board Meeting FY2018 · Q1BSEPDF 6. zář 2017 před 9 r. Výroční Financial Results for the year ended 31st March, 2017 FY2017BSEPDF 16. kvě 2017 před 9 r. Kvartální Bliss GVS Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 2016 2. Consolidated Financial Results for the period ended .... FY2017 · Q3BSEPDF 10. úno 2017 před 10 r. Kvartální Bliss GVS Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended September 30, 2016 2. Consolidated Financial Results for the period ended .... FY2017 · Q2BSEPDF 27. říj 2016 před 10 r. Kvartální Bliss GVS Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended June 30, 2016 2. Consolidated Financial Results for the period ended June 30, 2016 .... FY2017 · Q1BSEPDF 27. čvc 2016 před 10 r. Výroční Bliss GVS Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended March 31, 2016 2. Consolidated Financial Results for the period ended March 31, 2016 .... FY2016BSEPDF 25. kvě 2016 před 10 r. Kvartální Bliss GVS Pharma Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 2015 2. Standalone Limited Review for the period ended December 31, 2015 FY2016 · Q3BSEPDF 12. úno 2016 před 11 r. Kvartální With reference to the earlier Announcement dated November 09, 2015, regarding Financial Results for Sept 30, 2015, Bliss GVS Pharma Ltd has informed BSE that there is minor typographical .... FY2016 · Q2BSEPDF 10. lis 2015 před 11 r. Kvartální Bliss GVS Pharma Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended September 30, 2015. FY2016 · Q2BSEPDF 9. lis 2015 před 11 r. Kvartální Bliss GVS Pharma Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended June 30, 2015. FY2016 · Q1BSEPDF 14. srp 2015 před 11 r. Výroční Bliss GVS Pharma Ltd has informed BSE about the Financial Results for the period ended March 31, 2015. FY2015BSEPDF 29. kvě 2015 před 11 r. Kvartální Bliss GVS Pharma Ltd has informed BSE about the Standalone Financial Results & a copy of the Limited Review Report for the period ended December 31, 2014. FY2015 · Q3BSEPDF 13. úno 2015 před 12 r.